Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
deregulations involved in the development and progression of human lymphomas. The successful candidate will contribute to a research program aimed at generating, interpreting, and developing in vivo CRISPR Cas9
-
Cardioembolic Stroke Risk Stratification using AI Accelerated Patient-Specific Blood Flow Simulation
thrombogenesis. In this PhD project at Inria, in collaboration with the iCV team from Laboratoire d'Imagerie Biomédicale-LIB (Sorbonne University, Inserm), and the M2P2 team (Aix-Marseille University), we will
-
26 Feb 2026 Job Information Organisation/Company INSERM U1112 Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions Application Deadline 1 Apr
-
in cell sorting will be a big plus LanguagesENGLISHLevelExcellent Research FieldBiological sciences » BiologyYears of Research Experience4 - 10 Additional Information Benefits Inserm salary scale
-
of speech and music transmitted through maternal tissues. These rhythmic stimulations play a key role in cognitive development by supporting language acquisition, communication, and social interactions
-
Paris, France | Institut de l’Audition (Institut Pasteur) Duration: 24 months (flexible start) Supervisor: Keith Doelling (INSERM) About the position We are recruiting a postdoctoral researcher to
-
research organization (Inserm) and the Grandes Écoles (Centrale Nantes, École des Beaux-arts Nantes Saint-Nazaire, Ecole Nationale Supérieure d'Architecture de Nantes) Commitment to professional equality
-
follow the official INSERM scales. The position provides opportunities for independence, international networking, and leadership development in preparation for future fellowships. Eligibility criteria
-
12 Feb 2026 Job Information Organisation/Company Inserm PACA Corsica Department iBV - U1091 Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Positions
-
in oncology against breast cancer, with an ADC as active as Enhertu® in vivo but more stable during plasma circulation. The goal of this new project is to go even further by exploring the development